Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

AM03 Anti-Bak (Ab-1) Mouse mAb (TC-100)

This Anti-Bak (Ab-1) Mouse mAb (TC-100) is validated for use in Immunoblotting for the detection of Bak (Ab-1).

Anti-Bak (Ab-1) Mouse mAb (TC-100) : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: Anti-Bcl-2 Antagonist Killer

AM03
Purchase on Sigma-Aldrich

Aperçu

Replacement Information

Tableau de caractéristiques principal

HostAntibody Type
MMonoclonal Antibody

Products

RéférenceConditionnement Qté
AM03-100UG Ampoule plast. 100 μg
Description
OverviewRecognizes the ~30 kDa (apparent MW) Bak protein in HL-60 cells.
Catalogue NumberAM03
Brand Family Calbiochem®
SynonymsAnti-Bcl-2 Antagonist Killer
Application Data
Detection of human Bak by immunoblotting. Sample: Whole cell lysates from untreated HL-60 cells. Primary antibody: Anti-Bak (Ab-1) Mouse mAb (TC-100) (Cat. No. AM03) (2 µg/ml). Detection: chemiluminescence.
References
ReferencesChittenden, T., et al. 1995. Nature 374, 733.
Farrow, S.N., et al. 1995. Nature 374, 731.
Kiefer, M.C., et al. 1995. Nature 736.
Reed, J.C. 1994. J. Cell Biol. 124, 1.
Korsmeyer, S.J., et al. 1993. N. Semin. Cancer Biol. 4, 327.
Product Information
FormLiquid
FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
Positive controlHL-60 cells
Preservative≤0.1% sodium azide
Quality LevelMQ200
Applications
Application ReferencesImmunocytochemistry Panaretakis, T., et al. 2002. J. Biol. Chem. 277, 44317.
Key Applications Immunoblotting (Western Blotting)
Application NotesImmunoblotting (2.5 µg/ml, chemiluminescence)
Immunocytochemistry (see comments; see application references)
Application CommentsThis antibody recognizes active/activated Bak under nondenaturing, native conditions using applications like immunocytochemistry (see application references). Antibody should be titrated for optimal results in individual systems for each application.
Biological Information
Immunogenrecombinant human Bak from which the C-terminal and transmembrane domains have been deleted
ImmunogenHuman
EpitopeWithin the N-terminal region
CloneTC-100
HostMouse
IsotypeIgG2a
Antibody TypeMonoclonal Antibody
Concentration Label Please refer to vial label for lot-specific concentration
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Blue Ice Only
Toxicity Standard Handling
Storage +2°C to +8°C
Do not freeze Yes
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Référence GTIN
AM03-100UG 04055977227970

Documentation

Anti-Bak (Ab-1) Mouse mAb (TC-100) Certificats d'analyse

TitreNuméro de lot
AM03

Références bibliographiques

Aperçu de la référence bibliographique
Chittenden, T., et al. 1995. Nature 374, 733.
Farrow, S.N., et al. 1995. Nature 374, 731.
Kiefer, M.C., et al. 1995. Nature 736.
Reed, J.C. 1994. J. Cell Biol. 124, 1.
Korsmeyer, S.J., et al. 1993. N. Semin. Cancer Biol. 4, 327.

Brochure

Titre
Caspases and other Apoptosis Related Tools Brochure

Citations

Titre
  • Lena Thyrell, et al. (2004) Interferon α-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathways. Journal of Biological Chemistry 279, 24152-24162.
  • Aleksandra Mandic, et al. (2001) Cisplatin induces the proapoptotic conformation of Bak in a ΔMEKK1-dependent manner. Molecular and Cellular Biology 21, 3684-3691.
    		•
    Fiche technique

    Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

    Revision17-August-2007 RFH
    SynonymsAnti-Bcl-2 Antagonist Killer
    ApplicationImmunoblotting (2.5 µg/ml, chemiluminescence)
    Immunocytochemistry (see comments; see application references)
    Application Data
    Detection of human Bak by immunoblotting. Sample: Whole cell lysates from untreated HL-60 cells. Primary antibody: Anti-Bak (Ab-1) Mouse mAb (TC-100) (Cat. No. AM03) (2 µg/ml). Detection: chemiluminescence.
    DescriptionPurified mouse monoclonal antibody generated by immunizing mice with the specified immunogen and fusing splenocytes with Sp2/0 mouse myeloma cells. Recognizes the ~30 (apparent MW) kDa Bak protein.
    BackgroundBak (for bcl-2 homologous antagonist/killer) is a member of the bcl-2 family of proteins. Bak was independently identified by three different groups using either the two hybrid system for identifying adenovirus E1B 19K interacting proteins or by PCR cloning using degenerate BH1 and BH2 domain primers derived from the human bcl-2 gene. Bak shows a 53% homology with bcl-2 in the BH1 and BH2 domains but an overall homology of 28% with bcl-2. The presence of a hydrophobic tail on the protein suggests that, like bcl-2, it is membrane localized. The Bak protein is translated from a 2.2 kb mRNA to yield a 211-216 amino acid protein with a predicted molecular weight of 23.4 kDa but migrates by gel electrophoresis as an approximately 30 kDa protein under denaturing conditions. The bak gene (bak-1) has been mapped to chromosome 6 and spans approximately 6 kb of DNA. Southern analysis has indicated the presence of two additional bak genes: bak-2 has 97% homology with bak-1 and maps to chromosome 20, and bak-3, a pseudogene, which maps to chromosome 11. Functionally, bak is similar to bax in that it induces apoptosis. The protein pairs with bcl-xL but unlike its pairing partner, has been found in most tissues tested. While conflicting reports exist for the heterodimerization of bak with other members of the bcl-2 family of proteins, it is clear that bak does partner with the E1B 19K protein.
    HostMouse
    Immunogen speciesHuman
    Immunogenrecombinant human Bak from which the C-terminal and transmembrane domains have been deleted
    EpitopeWithin the N-terminal region
    CloneTC-100
    IsotypeIgG2a
    Specieshuman, not mouse, not rat
    Positive controlHL-60 cells
    FormLiquid
    FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
    Concentration Label Please refer to vial label for lot-specific concentration
    Preservative≤0.1% sodium azide
    CommentsThis antibody recognizes active/activated Bak under nondenaturing, native conditions using applications like immunocytochemistry (see application references). Antibody should be titrated for optimal results in individual systems for each application.
    Storage +2°C to +8°C
    Do Not Freeze Yes
    Toxicity Standard Handling
    ReferencesChittenden, T., et al. 1995. Nature 374, 733.
    Farrow, S.N., et al. 1995. Nature 374, 731.
    Kiefer, M.C., et al. 1995. Nature 736.
    Reed, J.C. 1994. J. Cell Biol. 124, 1.
    Korsmeyer, S.J., et al. 1993. N. Semin. Cancer Biol. 4, 327.
    Citation
  • Lena Thyrell, et al. (2004) Interferon α-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathways. Journal of Biological Chemistry 279, 24152-24162.
  • Aleksandra Mandic, et al. (2001) Cisplatin induces the proapoptotic conformation of Bak in a ΔMEKK1-dependent manner. Molecular and Cellular Biology 21, 3684-3691.
    		•
    Application referencesImmunocytochemistry Panaretakis, T., et al. 2002. J. Biol. Chem. 277, 44317.